Biology of glioma cancer stem cells

被引:140
作者
Park, Deric M. [1 ,2 ,3 ]
Rich, Jeremy N. [4 ]
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA
[4] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA
关键词
brain tumor; cancer stem cell; glioma; glioblastoma; BEVACIZUMAB PLUS IRINOTECAN; ACUTE MYELOID-LEUKEMIA; PROSPECTIVE IDENTIFICATION; NEURAL PROGENITORS; BRAIN CANCER; NF1; GENE; INACTIVATION; EXPRESSION; TEMOZOLOMIDE;
D O I
10.1007/s10059-009-0111-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gliomas, much like other cancers, are composed of a heterogeneous mix of neoplastic and non-neoplastic cells that include both native and recruited cells. There is extensive diversity among the tumor cells, with differing capacity for in vitro and in vivo growth, a property intimately linked to the cell's differentiation status. Those cells that are undifferentiated, self-renewing, with the capacity for developing tumors (tumorigenic) cells are designated by some as cancer stem cells, because of the stem-like properties. These cells may be a critical therapeutic target. However the exact identity and cell(s) of origin of the so-called glioma cancer stem cell remain elusive. Here we review the current understanding of glioma cancer stem cell biology.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 76 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient [J].
Amariglio, Ninette ;
Hirshberg, Abraham ;
Scheithauer, Bernd W. ;
Cohen, Yoram ;
Loewenthal, Ron ;
Trakhtenbrot, Luba ;
Paz, Nurit ;
Koren-Michowitz, Maya ;
Waldman, Dalia ;
Leider-Trejo, Leonor ;
Toren, Amos ;
Constantini, Shlomi ;
Rechavi, Gideon .
PLOS MEDICINE, 2009, 6 (02) :221-231
[3]  
Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940
[4]   Epidermal growth factor receptor and Ink4a/Arf:: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis [J].
Bachoo, RM ;
Maher, EA ;
Ligon, KL ;
Sharpless, NE ;
Chan, SS ;
You, MJJ ;
Tang, Y ;
DeFrances, J ;
Stover, E ;
Weissleder, R ;
Rowitch, DH ;
Louis, DN ;
DePinho, RA .
CANCER CELL, 2002, 1 (03) :269-277
[5]   Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation [J].
Bajenaru, ML ;
Zhu, Y ;
Hedrick, NM ;
Donahoe, J ;
Parada, LF ;
Gutmann, DH .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (14) :5100-5113
[6]   Targeting cancer stem cells through L1CAM suppresses glioma growth [J].
Bao, Shideng ;
Wu, Qiulian ;
Li, Zhizhong ;
Sathornsumetee, Sith ;
Wang, Hui ;
McLendon, Roger E. ;
Hjehneland, Anita B. ;
Rich, Jeremy N. .
CANCER RESEARCH, 2008, 68 (15) :6043-6048
[7]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[8]   Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor [J].
Bao, Shideng ;
Wu, Qiulian ;
Sathornsumetee, Sith ;
Hao, Yueling ;
Li, Zhizhong ;
Hjelmeland, Anita B. ;
Shi, Oing ;
McLendon, Roger E. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
CANCER RESEARCH, 2006, 66 (16) :7843-7848
[9]   Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma [J].
Bar, Eli E. ;
Chaudhry, Aneeka ;
Lin, Alex ;
Fan, Xing ;
Schreck, Karisa ;
Matsui, William ;
Piccirillo, Sara ;
Vescovi, Angelo L. ;
DiMeco, Francesco ;
Olivi, Alessandro ;
Eberharta, Charles G. .
STEM CELLS, 2007, 25 (10) :2524-2533
[10]   Temozolomide preferentially depletes cancer stem cells in glioblastoma [J].
Beier, Dagmar ;
Roehrl, Stefanie ;
Pillai, Deepu R. ;
Schwarz, Stefanie ;
Kunz-Schughart, Leoni A. ;
Leukel, Petra ;
Proescholdt, Martin ;
Brawanski, Alexander ;
Bogdahn, Ulrich ;
Trampe-Kieslich, Ariane ;
Giebel, Bernd ;
Wischhusen, Joerg ;
Reifenberger, Guido ;
Hau, Peter ;
Beier, Christoph P. .
CANCER RESEARCH, 2008, 68 (14) :5706-5715